The IMPORT HIGH Trial: A Paradigm Shift in Early Breast Cancer Treatment with Simultaneous Integrated Boost

Breast cancer accounts for 12.5% of all new cancer cases each year worldwide, making it the most prevalent cancer at the moment. In 2020, an estimated 7.8 million women …










